Renovaro Inc (RENB)
1.49
+0.02
(+1.36%)
USD |
NASDAQ |
May 31, 16:00
1.46
-0.03
(-2.01%)
After-Hours: 20:00
Renovaro Cash from Operations (Quarterly): -2.634M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -2.634M |
December 31, 2023 | -3.147M |
September 30, 2023 | -2.777M |
June 30, 2023 | -2.262M |
March 31, 2023 | -3.308M |
December 31, 2022 | -3.552M |
September 30, 2022 | -2.654M |
June 30, 2022 | -3.050M |
March 31, 2022 | -2.785M |
December 31, 2021 | -4.620M |
September 30, 2021 | -5.277M |
June 30, 2021 | -13.03M |
March 31, 2021 | -2.331M |
December 31, 2020 | -2.496M |
September 30, 2020 | -2.756M |
June 30, 2020 | -2.245M |
March 31, 2020 | -3.838M |
December 31, 2019 | -2.575M |
September 30, 2019 | -1.801M |
June 30, 2019 | -2.219M |
March 31, 2019 | -2.738M |
December 31, 2018 | -1.754M |
September 30, 2018 | -1.797M |
June 30, 2018 | -1.612M |
March 31, 2018 | -1.732M |
Date | Value |
---|---|
December 31, 2017 | -0.4877M |
September 30, 2017 | -0.5069M |
June 30, 2017 | -0.499M |
March 31, 2017 | -0.0277M |
December 31, 2016 | -0.3243M |
September 30, 2016 | -0.3265M |
June 30, 2016 | -0.3103M |
March 31, 2016 | -0.0792M |
December 31, 2015 | -0.6668M |
September 30, 2015 | -0.416M |
March 31, 2015 | -2.044M |
December 31, 2014 | -0.9312M |
September 30, 2014 | -0.461M |
June 30, 2014 | -0.2042M |
March 31, 2014 | -0.4377M |
December 31, 2013 | -0.0168M |
September 30, 2013 | -0.0097M |
June 30, 2013 | -0.007M |
March 31, 2013 | -0.0024M |
December 31, 2012 | -0.0096M |
September 30, 2012 | -0.007M |
June 30, 2012 | -0.011M |
March 31, 2012 | -0.0048M |
December 31, 2011 | -0.0111M |
September 30, 2011 | -0.0049M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-13.03M
Minimum
Jun 2021
-1.801M
Maximum
Sep 2019
-3.468M
Average
-2.766M
Median
Cash from Operations (Quarterly) Benchmarks
DIH Holding US Inc | -- |
AIM ImmunoTech Inc | -4.815M |
Perspective Therapeutics Inc | 13.85M |
Protalix BioTherapeutics Inc | 4.188M |
Armata Pharmaceuticals Inc | -10.58M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -0.0916M |
Cash from Financing (Quarterly) | 2.641M |
Free Cash Flow | -10.87M |
Free Cash Flow Per Share (Quarterly) | -0.0246 |
Free Cash Flow Yield | -9.85% |